The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...
Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims ...
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in ...
( WJET/WFXP) — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle ...
The tentative deal is worth more than $7 billion. It includes the company's owners, members of the Sackler family. However, it does not give them immunity from future opioid lawsuits as the family ...
Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
The plan put forth Tuesday could see the Sackler family pay up to $7 billion. Also in the news: Merck prepares to close its manufacturing plant in Pennsylvania; Optum Rx, which includes UnitedHealth ...
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...
A previous version had bankruptcy court approval but was rejected last year by the U.S. Supreme Court because it protected members of the Sackler family from civil lawsuits even though none of ...